ReportBuyer.com, the online destination for business intelligence for major industry sectors, has added a new report describing the specific segment of the life sciences market called DNA sequencing.

The publication DNA Sequencing and PCR Markets includes all of the generally-accepted DNA-oriented analytical activities that are currently used today, such as enabling technologies like polymerase chain reaction (PCR).

The report examines the measurement technology platforms and their reagents and supplies as utilised in biotechnology research, pharmacology and healthcare.
It further identifies viable technology drivers through a comprehensive look at various platform technologies for molecular sequencing, including immunoassays electrophoretic methods, probe-based nucleic acid assays, microarrays and non-PCR sequencing;

Authors of the report note that the report obtains a complete understanding of the chief molecular sequencing tests for predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic applications. Furthermore it discovers feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets-communicable diseases, cardiology and oncology; and

ReportBuyer.com Product ID: TRI00027

ReportBuyer.com Category: Pharma and Healthcare